天智航(688277.SH):TKA全膝關節置換機器人臨牀試驗入組工作已全部完成
格隆匯4月20日丨天智航(688277.SH)公佈,公司的骨科手術導航定位系統TiRobot Recon(即TKA全膝關節置換機器人)臨牀試驗入組工作即臨牀試驗手術已全部完成。
骨科手術機器人主要應用於三類手術,即關節置換手術、脊柱手術及骨科創傷手術。機器人輔助關節置換手術是應用廣泛且相對複雜的一類手術。在TKA中應用手術機器人可提高截骨及假體植入精度,從而獲得更優的手術效果並延長植入物的壽命。目前公司骨科手術導航定位系統TiRobot Recon臨牀試驗入組工作已完成。
截至目前,公司已上市並實現銷售的骨科手術機器人有天璣1.0和天璣2.0產品,公司天璣1.0和天璣2.0產品主要應用於脊柱手術和骨科創傷手術,適應證覆蓋頸椎、胸椎、腰椎、骶椎全節段脊柱外科手術和骨盆、髖臼、四肢等部位的創傷手術。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.